Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-27T02:41:15.289Z Has data issue: false hasContentIssue false
  • English
  • Français

Metronidazole

Published online by Cambridge University Press:  02 January 2015

Mark Eggleston
Mark Eggleston*
Affiliation:
Epidemiology Department, Potomac Hospital, Woodbridge, Virginia
*
Epidemiology Department, Potomac Hospital, 2300 Optic Building, Woodbridge, VA 22191
Get access Rights & Permissions [Opens in a new window]

Extract

Metronidazole was introduced to the market in 1959 as the only effective therapy for Trichomonas vaginalis. A nitroimidazole derivative, its success in the therapy of parasitic infections, including Entamoeba histolytica and Giardia lamblia, has been well documented. Metronidazole's activity against anaerobic bacteria was first described in 1962 by Shinn, and by Davies and associates in 1964. In both reports, metronidazole effectively treated patients with Vincent's angina (necrotizing ulcerative gingivitis). Metronidazole's excellent activity against anaerobes has been substantiated by numerous articles. It has the best bactericidal activity of all drugs active against anaerobic bacteria.

Type
Special Sections
Information
Infection Control & Hospital Epidemiology , Volume 7 , Issue 10 , October 1986 , pp. 514 - 518
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1986

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Powell, SJ, MacLeod, l, Wilmot, AJ, Elsdon-Dew, R: Metronidazole in amoebic dysentery and amoebic liver abscess. Lancet 1966; 2:1329–1331.Google Scholar
2.Khambatta, RB: Metronidazole in giardiasis. Ann Trap Med Parasilol 1971; 65:487–489.CrossRefGoogle ScholarPubMed
3.Shinn, DLS: Metronidazole in acute ulcerative gingivitis (letter to the editor). Lancet 1962; 1:1191.CrossRefGoogle Scholar
4.Davies, AH, McFadzean, JA, Squires, S: Treatment of Vincent's stomatitis with metronidazole. Br Med J 1964; 1:1149–1150.Google Scholar
5.Ueno, K, Ninomiya, K, Suzuki, S: Antibacterial activity of metronidazole against Bacteroides fragilis. Chemother Jpn 1971; 19:111–114.Google Scholar
6.Tally, FP, Sutter, VL, Finegold, SM: Metronidazole versus anaerobes: In vitro data and initial clinical observations. Calif Med December 1972; 117:22–26.Google Scholar
7.Nastro, LJ, Finegold, SM: Bactericidal activity of five antimicrobial agents against Bacteroides fragilis. J Infect Dis 1972; 126:104–107.CrossRefGoogle ScholarPubMed
8.Finegold, SM, George, WL, Rolfe, RD (eds): First United States metronidazole conference. Proc Symp, Tarpon Springs, FL, February 1982. New York, Biomedical Information Corp., 1982.Google Scholar
9.Larusso, NJ, Tomasz, M, Muller, M, Lipman, R: Interaction of metronidazole with nucleic acids in vitro. Mol Pharmacol 1977; 13:872–888.Google Scholar
10.Knight, RC, Skolimowski, IM, Edwards, DI: The interaction of reduced metronidazole with DNA. Biochem Pharmacol 1978; 27:2089–2093.CrossRefGoogle ScholarPubMed
11.Müller Rhone, M: Mode of action of metronidazole on anaerobic bacteria and protozoa, in Rhone - Poulenc Pharma Inc., Montreal, Proc North American Metronidazole Symp, Anaerobic Infections, Scottsdale, AZ, October 1981. Surgery 1983; 93:165.Google Scholar
12.O'Keefe, JP, Troc, KA, Thompson, KD: Activity of metronidazole and its hydroxy and acid metabolites against clinical isolates of anaerobic bacteria. Antimicrob Agents Chemother 1982; 22:426–430.Google Scholar
13.Tally, FP, Sullivan, CE: Metronidazole: In vitro activity, pharmacology and efficacy in anaerobic bacterial infections. Pharmacotherapy 1981; 1:28.CrossRefGoogle ScholarPubMed
14.Corrodi, P, Busch, DF, Sutter, CL, et al: Factors affecting the in vitro antibacterial activity of metronidazole, in Finegold, SM, McFadzean, JA, Roe, FJC (eds): Metronidazole. Proc Int Metronidazole Conf, Montreal, May 1976, Princeton, NJ. Excerpta Medica, 1977, p 299.Google Scholar
15.McGilveray, IJ, Midha, KK, Loo, JC, Cooper, JK: The bioavailability of commercial metronidazole formulations. Int J Clin Pharmacol Biopharm 1978; 16:110–115.Google Scholar
16.Mattila, J, Nerdrum, K, Rouhiainen, H, et al: Penetration of metronidazole and tinidazole into the aqueous humor in man. Chemotherapy 1983; 29:188.CrossRefGoogle ScholarPubMed
17.Cerat, GA, Cerat, LL, McHenry, MC, et al: Metronidazole in renal failure. Excerpta Medica (International Congress Series) no 438, 1976; pp 404–414.Google Scholar
18.Gabriel, R: The pharmacokinetics of metronidazole in patients with chronic renal failure, in Philips, I, Collier, J (eds): Metronidazole: Proceedings of the Second International Symposium on Anaerobic Infections. New York, Academic Press, 1979; pp 49–54.Google Scholar
19.Chow, AW, Patten, V, Guze, LB: Susceptibility of anaerobic bacteria to metronidazole: Relative resistance of non-spore-forming gram positive bacilli. J Infect Dis 1975; 131:182–185.CrossRefGoogle Scholar
20.Brogden, RN, Heel, RC, Speight, TM, Avery, GS: Metronidazole in anaerobic infections: A review of its activity, pharmacokinetics and therapeutic use. Drugs 1978; 16:387–417.CrossRefGoogle ScholarPubMed
21.Ralph, ED, Kirby, WMM: Unique bactericidal action of metronidazole against Bacteroides fragilis and Clostridium perfringens. Antimicrob Agents Chemother 1975; 8:409–414.Google Scholar
22.Rosenblatt, JE, Edson, RS: Metronidazole. Mayo Clin Proc 1983; 58:154–157.Google ScholarPubMed
23.Wust, J: Susceptibility of anaerobic bacteria to metronidazole, ornidazole, and tinidazole and routine susceptibility testing by standardized methods. Antimicrob Agents Chemother 1977; 11:631.Google Scholar
24.Finegold, SM: Metronidazole. Ann Intern Med 1980; 93:585.Google Scholar
25.Chow, AW, Bednorz, D, Guze, LB: Susceptibility of obligate anaerobes to metronidazole: An extended study of 1,054 clinical isolates, in Finegold, SM, McFadzean, JA, Roe, FJC (eds): Metronidazole. Proc Int Metronidazole Conf, Montreal, May 1976. Princeton, NJ, Excerpta Medica, 1977, p 286.Google Scholar
26.Rissing, JP, Moore, WL Jr, Newman, C, et al: Treatment of anaerobic infections with metronidazole. Curr Ther Res 1980; 27:651–663.Google Scholar
27.Giamarellou, H, Kanellakopoulou, K, Pragastis, D, et al: Treatment with metronidazole of 48 patients with serious anaerobic infections. J Antimicrob Chemother 1977; 3:347–353.Google Scholar
28.Galgiani, JN, Busch, DF, Brass, C, et al: Bacteroides fragilis endocarditis, bacteremia, and other infections treated with oral or intravenous metronidazole. Am J Med 1978; 65:284–289.Google Scholar
29.Wagner, JF, Perkins, RL, Cordero, L: Metronidazole therapy of anaerobic bacteremia, meningitis, and brain abscess. Arch Intern Med 1979; 138:167–169.Google Scholar
30.Eykyn, SJ, Phillips, I: Metronidazole in surgical infections. J Antimicrob Chemother 1978; 4(Suppl C):75–81.Google Scholar
31.Onderdonk, AB, Louie, TJ, Tally, FP, Bartlett, JG: Activity of metronidazole against Escherichia coli in experimental intra-abdominal sepsis. J Antimicrob Chemother 1979; 5:201–210.Google Scholar
32.Bartlett, JG, Louie, TJ, Gorbach, SL, Onderdonk, AB: Therapeutic efficacy of 29 antimicrobial regimens in experimental intra-abdominal sepsis. Rev Infect Dis 1981; 3:535–542.Google Scholar
33.Reznikow, M, McDonald, PJ: Effect of metronidazole on Escherichia coli in the presence of Bacteroides fragilis: An investigation in mice. Chemotherapy 1983; 29:225.Google Scholar
34.Spiegel, CA, Amsel, R, Eschenbach, D, et al: Anaerobic bacteria in nonspecific vaginitis. N Engl J Med 1980; 303:601–607.Google Scholar
35.Baldson, MJ, Taylor, GE, Pead, L, Maskell, R: Corynebacterium vaginale and vaginitis: A controlled trial of treatment. Lancet 1980; 1:501–504.Google Scholar
36.Ralph, ED, Amatnieks, YE: Metronidazole in treatment against Haemophilus vaginalis {Corynebacterium vaginale). Antimicrob Agents Chemother 1980; 18:101–104.CrossRefGoogle ScholarPubMed
37.Sutter, VL: In vitro susceptibility of anaerobic and microaerophilic bacteria to metronidazole and its hydroxy metabolite, in Finegold, SM, George, WL, Rolfe, RD (eds): First United States Metronidazole Conference. Proc Symp, Tarpon Springs, FL, February 1982. New York, Biomedical Information Corp, 1982, p 61.Google Scholar
38.Werner, H, Schadler, G, Kraseman, C: In vitro activity of azlocillin, metronidazole and its hydroxy metabolite against anaerobes. Arzneimittelforsch Drug Res 1983; 33:574.Google ScholarPubMed
39.Davies, AH: Metronidazole in human infections with syphilis. Br J Vener Dis 1967; 43:197–200.Google ScholarPubMed
40.Philips, I, Warren, C, Taylor, E, et al: The antimicrobial susceptibility of anaerobic bacteria in a London teaching hospital. J Antimicrob Chemother 1981; 8:17.Google Scholar
41.Tally, FP, Snydman, DR, Shimell, MJ, et al: Mechanisms of antimicrobial resistance of Bacteroides fragilis, in Philips, I, Collier, J (eds): Metronidazole. Proc Second Int Symp Anaerobic Infections, Geneva, April 1979. London, The Royal Society of Medicine and Academic Press, and New York, Grune and Stratton, 1979, p 83.Google Scholar
42.Sanders, CV, Hanna, BJ, Lewis, AZ, et al: The use of metronidazole in the treatment of anaerobic pleuropulmonary infections, in Phillips, I, Collier, J (eds): Metronidazole. Proc Second Int Symp Anaerobic Infections, Geneva, April 1979. London, The Royal Society of Medicine, New York, Grune and Stratton, 1979.Google Scholar
43.Drenick, EJ: Extraintestinal complications of jejunoileal bypass for obesity, in Finegold, SM, George, WL, Rolfe, RD (eds): First United States Metronidazole Conference, Proc Symp, Tarpon Springs, FL, February 1982. New York, Biomedical Information Corp., 1982, p 371.Google Scholar
44.Kelly, DG, Phillips, SF, Kelly, KA, et al: Dysfunction of the continent ileostomy: Clinical features and bacteriology. Gut 1983; 24:193.Google Scholar
45.Capron, JP, Herve, MA, Gineston, JL, et al: Metronidazole in prevention of cholestasis associated with total parenteral nutrition. Lancet 1983; 1:446.Google Scholar
46.Eykyn, JJ, Jackson, BT, Lockhart-Mummery, HE, Phillips, I: Prophylactic preoperative intravenous metronidazole in elective colorectal surgery. Lancet 1979; 2:761–764.CrossRefGoogle ScholarPubMed
47.Bernstein, LH, Frank, MJ, Brandt, LJ, Boley, JJ: Healing of perineal Chron's disease with metronidazole. Gastroenterology 1980; 79:357–365.Google Scholar
48.Rissing, JP, Newman, C, Moore, WL Jr: Artifactual depression of serum glutamic oxaloacetic transaminase by metronidazole. Antimicrob Agents Chemother 1978; 14:636–638.Google Scholar
49.Roe, JFC: A critical appraisal of the toxicology of metronidazole, in Phillips, I, Collier, J (eds): Metronidazole: Proceedings of the Second International Symposium on Anaerobic Infections. New York, Academic Press, 1979, pp 215–222.Google Scholar
50.Rustia, M, Shubik, P: Experimental induction of hepatomas, mammary tumors and other tumors with metronidazole in non-inbred SAS: MRC (WI) BR rats. J Natl Cancer Inst 1979; 63: 863–867.Google Scholar
51.Rosenkranz, HS, Speck, WT: Mutagenicity of metronidazole: Activation by mammalian liver microsomes. Biochem Biophys Res Commun 1975; 66:520–525.Google Scholar
52.McCann, J, Ames, BN: Detection of carcinogens as mutagens in the salmonella/microsome test: Assay of 300 chemicals. Proc Natl Acad Sci USA 1976, 73:950–954.CrossRefGoogle ScholarPubMed
53.Beard, CM, Noller, KL, O'Fallon, WM, et al: Lack of evidence for cancer due to use of metronidazole. N Engl J Med 1979; 301:519–522.Google Scholar
54.Friedman, GD: Cancer after metronidazole (Letter to the Editor). N Engl J Med 1980; 302:519.Google Scholar
55.Kazmier, FJ: A significant interaction between metronidazole and warfarin. Mayo Clin Proc 1976; 51:782–784.Google Scholar
56.Lewis, RP, Wideman, P, Sutter, VL, et al: The effect of metronidazole on human fecal flora, in Finegold, SM, McFadzean, JA, Roe, FJC (eds): Metronidazole. Proc Int Metronidazole Conf, Montreal, May 1976. Princeton, NJ, Excerpta Medica, 1977, p 307.Google Scholar
57.Ralph, ED, Kirby, WMM: Human pharmacology of oral metronidazole as determined by Bioassay. Excerpta Medica (International (Congress Series) no 438, 1976, pp 50–57.Google Scholar